Cepeda Yamila, Elizondo-Vega Roberto, Garrido Camila, Tobar Catalina, Araneda Matías, Oliveros Patricia, Ordenes Patricio, Carril Claudio, Vidal Pía M, Luz-Crawford Patricia, García-Robles María A, Oyarce Karina
Laboratorio de Neuroinmunología, Facultad de Medicina y Ciencia, Universidad San Sebastián, Sede Concepción, Concepción, Chile.
Laboratorio de Biología Celular, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.
Front Cell Neurosci. 2024 Aug 14;18:1406832. doi: 10.3389/fncel.2024.1406832. eCollection 2024.
Major depression disorder (MDD) and anxiety are common mental disorders that significantly affect the quality of life of those who suffer from them, altering the person's normal functioning. From the biological perspective, the most classical hypothesis explaining their occurrence relies on neurotransmission and hippocampal excitability alterations. However, around 30% of MDD patients do not respond to medication targeting these processes. Over the last decade, the involvement of inflammatory responses in depression and anxiety pathogenesis has been strongly acknowledged, opening the possibility of tackling these disorders from an immunological point of view. In this context, regulatory T cells (Treg cells), which naturally maintain immune homeostasis by suppressing inflammation could be promising candidates for their therapeutic use in mental disorders.
To test this hypothesis, C57BL/6 adult male mice were submitted to classical stress protocols to induce depressive and anxiety-like behavior; chronic restriction stress (CRS), and chronic unpredictable stress (CUS). Some of the stressed mice received a single adoptive transfer of Treg cells during stress protocols. Mouse behavior was analyzed through the open field (OFT) and forced swim test (FST). Blood and spleen samples were collected for T cell analysis using cell cytometry, while brains were collected to study changes in microglia by immunohistochemistry.
Mice submitted to CRS and CUS develop anxiety and depressive-like behavior, and only CRS mice exhibit lower frequencies of circulating Treg cells. Adoptive transfer of Treg cells decreased anxiety-like behavior in the OFT only in CRS model, but not depressive behavior in FST in neither of the two models. In CRS mice, Treg cells administration lowered the number of microglia in the hippocampus, which increased due this stress paradigm, and restored its arborization. However, in CUS mice, Treg cells administration increased microglia number with no significant effect on their arborization.
Our results for effector CD4 T cells in the spleen and microglia number and morphology in the hippocampus add new evidence in favor of the participation of inflammatory responses in the development of depressive and anxiety-like behavior and suggest that the modulation of key immune cells such as Treg cells, could have beneficial effects on these disorders.
重度抑郁症(MDD)和焦虑症是常见的精神障碍,严重影响患者的生活质量,改变其正常功能。从生物学角度来看,解释其发病的最经典假说是基于神经传递和海马体兴奋性改变。然而,约30%的MDD患者对针对这些过程的药物没有反应。在过去十年中,炎症反应在抑郁症和焦虑症发病机制中的作用已得到广泛认可,这为从免疫学角度治疗这些疾病提供了可能性。在这种情况下,通过抑制炎症自然维持免疫稳态的调节性T细胞(Treg细胞)可能是治疗精神障碍的有前景的候选者。
为了验证这一假说,将C57BL/6成年雄性小鼠置于经典应激方案下以诱导抑郁和焦虑样行为;慢性限制应激(CRS)和慢性不可预测应激(CUS)。一些应激小鼠在应激方案期间接受了一次Treg细胞的过继转移。通过旷场试验(OFT)和强迫游泳试验(FST)分析小鼠行为。采集血液和脾脏样本,使用细胞流式术进行T细胞分析,同时采集大脑样本,通过免疫组织化学研究小胶质细胞的变化。
接受CRS和CUS的小鼠出现焦虑和抑郁样行为,只有CRS小鼠循环Treg细胞频率较低。Treg细胞的过继转移仅在CRS模型中降低了OFT中的焦虑样行为,但在两个模型中均未降低FST中的抑郁行为。在CRS小鼠中,给予Treg细胞降低了海马体中小胶质细胞的数量,该数量因这种应激模式而增加,并恢复了其分支。然而,在CUS小鼠中,给予Treg细胞增加了小胶质细胞数量,对其分支没有显著影响。
我们关于脾脏中效应性CD4 T细胞以及海马体中小胶质细胞数量和形态的研究结果为炎症反应参与抑郁和焦虑样行为的发展提供了新证据,并表明调节关键免疫细胞如Treg细胞可能对这些疾病有有益影响。